|
|
(14 intermediate revisions by 3 users not shown) |
Line 1: |
Line 1: |
| <StructureSection load='1akn' size='300' side='right' caption='Structure of Pancreatic Lipase (PDB entry [[1akn]])' scene=''> | | <StructureSection load='1akn' size='300' side='right' caption='Structure of glycosylated pancreatic lipase (PDB entry [[1akn]])' scene=''> |
| {{TOC limit|limit=2}} | | {{TOC limit|limit=2}} |
|
| |
|
Line 13: |
Line 13: |
| [[Image:Picture 1.png]] | | [[Image:Picture 1.png]] |
| Further breakdown ultimately results in 2-monoacylglycerols and free fatty acids <ref name= "A cross-linked complex between horse pancreatic lipase and colipase">[http://www.sciencedirect.com/science/article/pii/0014579389815923] A cross-linked complex between horse pancreatic lipase and colipase</ref>. An in depth discussion of the mechanism can be found in the Lipase Catalytic Mechanism section. The determination of the structure and function of lipase was a gradual process. Lipase activity was first demonstrated in the pancreas by Claude Bernard in 1846. However, it wasn't until 1955 that Mattson and Beck demonstrated a high-specificity of pancreatic lipase for triglyceride primary esters <ref name= "History of Lipids">[http://www.cyberlipid.org/history/history1.htm] History of Lipids</ref>. In recent years, determination of the crystal structure of pancreatic lipase has become the primary focus as many scientists have worked to further this.<br /> | | Further breakdown ultimately results in 2-monoacylglycerols and free fatty acids <ref name= "A cross-linked complex between horse pancreatic lipase and colipase">[http://www.sciencedirect.com/science/article/pii/0014579389815923] A cross-linked complex between horse pancreatic lipase and colipase</ref>. An in depth discussion of the mechanism can be found in the Lipase Catalytic Mechanism section. The determination of the structure and function of lipase was a gradual process. Lipase activity was first demonstrated in the pancreas by Claude Bernard in 1846. However, it wasn't until 1955 that Mattson and Beck demonstrated a high-specificity of pancreatic lipase for triglyceride primary esters <ref name= "History of Lipids">[http://www.cyberlipid.org/history/history1.htm] History of Lipids</ref>. In recent years, determination of the crystal structure of pancreatic lipase has become the primary focus as many scientists have worked to further this.<br /> |
| =='''See also'''==<br /> | | |
| | ==See also== |
| * [[Molecular Playground/Pancreatic Lipase]]<br /> | | * [[Molecular Playground/Pancreatic Lipase]]<br /> |
| * [[Lipase lid morph]]<br /> | | * [[Lipase lid morph]]<br /> |
Line 20: |
Line 21: |
| * [[Monoglyceride lipase]]<br /> | | * [[Monoglyceride lipase]]<br /> |
| * [[Human gastric lipase]]<br /> | | * [[Human gastric lipase]]<br /> |
| | * [[Lipoprotein Lipase (LPL) complexed with GPIHBP1]]<br /> |
| * [[Lipase (Hebrew)]]<br /> | | * [[Lipase (Hebrew)]]<br /> |
| | * [[Lipid metabolism]] |
|
| |
|
| == '''Structure''' == | | == '''Structure''' == |
Line 60: |
Line 63: |
| == '''Clinical Significance''' == | | == '''Clinical Significance''' == |
| Pancreatic lipase is secreted into the duodenum through the duct system of the pancreas. In a healthy individual, it is at very low concentration in serum. Under extreme disruption of pancreatic function, such as pancreatitis or pancreatic cancer, the pancreas may begin to digest itself and release pancreatic enzymes including pancreatic lipase into serum. Measurement of serum concentration of pancreatic lipase can therefore aid in diagnosis of acute pancreatitis.<ref>"Pancreatic lipase". Wikipedia: The Free Encyclopedia. 7 Nov 2011 [http://en.wikipedia.org/wiki/Pancreatic_lipase]</ref>. Due to lipase's activity in the digestion and absorption of fat, there has been a growing market for lipase inhibitors for weight loss pharmaceuticals. The most popular is Orlistat (or Xenical®) which is a natural product from ''Streptomyces toxytricini'' and is the hydrogenation product of lipostation- an irreversible lipase inhibitor. This inhibitor also acts by binding Ser152, producing an ester which hydrolyzes so slow that it is practically irreversible <ref>Kordik, C., Reitz, A. "Pharmacological Treatment of Obesity: Therapeutic Strategies" Journal of Medicinal Chemistry, 1999 (42).</ref>. | | Pancreatic lipase is secreted into the duodenum through the duct system of the pancreas. In a healthy individual, it is at very low concentration in serum. Under extreme disruption of pancreatic function, such as pancreatitis or pancreatic cancer, the pancreas may begin to digest itself and release pancreatic enzymes including pancreatic lipase into serum. Measurement of serum concentration of pancreatic lipase can therefore aid in diagnosis of acute pancreatitis.<ref>"Pancreatic lipase". Wikipedia: The Free Encyclopedia. 7 Nov 2011 [http://en.wikipedia.org/wiki/Pancreatic_lipase]</ref>. Due to lipase's activity in the digestion and absorption of fat, there has been a growing market for lipase inhibitors for weight loss pharmaceuticals. The most popular is Orlistat (or Xenical®) which is a natural product from ''Streptomyces toxytricini'' and is the hydrogenation product of lipostation- an irreversible lipase inhibitor. This inhibitor also acts by binding Ser152, producing an ester which hydrolyzes so slow that it is practically irreversible <ref>Kordik, C., Reitz, A. "Pharmacological Treatment of Obesity: Therapeutic Strategies" Journal of Medicinal Chemistry, 1999 (42).</ref>. |
|
| |
| </StructureSection>
| |
|
| |
|
| == 3D Structures of Lipase == | | == 3D Structures of Lipase == |
| | [[Lipase 3D Structures]] |
|
| |
|
| Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
| | </StructureSection> |
| {{#tree:id=OrganizedByTopic|openlevels=0|
| |
| | |
| *Eukaryote lipase:
| |
| | |
| **[[1hpl]] – hLip – horse <br />
| |
| **[[1hlg]] – hLip – human - gastric<br />
| |
| **[[3jw8]], [[3hju]] – mono-glyceride hLip<br />
| |
| **[[1jmy]] – hBSSL <br />
| |
| **[[1akn]] – cBSSL – cattle <br />
| |
| **[[2bce]] - cBSSL (mutant) <br />
| |
| **[[1f6w]] - cBSSL – catalytic domain<br />
| |
| **[[3o0d]] – Lip – ''Yarrowia lipolytica''<br />
| |
| **[[4jei]] – YlLip (mutant)<br />
| |
| **[[1gpl]] – Lip – Guinea pig<br />
| |
| **[[3zpx]] – Lip – ''Ustilago maydis''<br />
| |
| | |
| *Prokaryote lipase:
| |
| | |
| **[[3guu]], [[1lbs]], [[1lbt]], [[1tca]], [[1tcb]], [[1tcc]] – CaLipA – ''Candida antarctica''<br />
| |
| **[[2veo]] – CaLipA – closed state<br />
| |
| **[[4k6g]] – CaLipB<br />
| |
| **[[3icv]], [[4k5q]], [[4k6h]], [[4k6k]] – CaLipB (mutant) <br />
| |
| **[[1gz7]], [[1lpm]], [[1lps]]– CrLip 2 – ''Candida rugosa'' - closed state<br />
| |
| **[[1crl]], [[1trh]] – CrLip – open state<br />
| |
| **[[1llf]] – Lip – ''Candida cylindracea''<br />
| |
| **[[3g7n]] – Lip - ''Penicillium expansum''<br />
| |
| **[[1tia]] - Lip – ''Penicillium camemberti''<br />
| |
| **[[2qua]], [[2qub]] – LipA – ''Serratia marcescens''<br />
| |
| **[[2hih]] – Lip – ''Staphylococcus hyicus''<br />
| |
| **[[2fx5]] – Lip – ''Pseudomonas mendocina''<br />
| |
| **[[1yzf]] – Lip – ''Enterococcus faecalis''<br />
| |
| **[[1dt3]], [[1dt5]], [[1dte]], [[1du4]], [[1ein]], [[1tib]], [[4dyh]], [[4ea6]], [[4flf]], [[4gbg]], [[4gwl]] - TlLip - ''Thermomyces lanuginose''<br />
| |
| **[[1jfr]] – Lip – ''Streptomyces exfoliates''<br />
| |
| **[[1oil]] – BcLip - ''Burkholderia cepacia''<br />
| |
| **[[2lip]] – BcLip – open state<br />
| |
| **[[1cvl]] – Lip – ''Chromobacterium viscosum''<br />
| |
| **[[1lgy]] – Lip II – ''Rhizopus niveus''<br />
| |
| **[[1tic]] - Lip – ''Rhizopus oryzae''<br />
| |
| **[[1thg]] – Lip – ''Geotrichum candidum''<br />
| |
| **[[3tgl]], [[4tgl]], [[1tgl]] – RmLip– ''Rhyzomucor miehei''<br />
| |
| **[[2zvd]] – PsLip - ''Pseudomonas sp.'' – open state<br />
| |
| **[[2z8x]] - PsLip – extracellular<br />
| |
| **[[2zj6]], [[2zj7]] – PsLip (mutant) <br />
| |
| **[[2z8z]] – PsLip(mutant) – closed state<br />
| |
| **[[3lip]], [[3a6z]] - Lip - ''Pseudomonas cepacia'' – open state<br />
| |
| **[[1qge]], [[1tah]] – Lip – ''Pseudomonas glumae''<br />
| |
| **[[2w22]] – Lip – ''Geobacillus thermocatenulatus''<br />
| |
| **[[1ji3]], [[1ku0]], [[4fmp]] – Lip – ''Bacillus stearothermophilus''<br />
| |
| **[[1ah7]] - Lip – ''Bacillus cereus''<br />
| |
| **[[2qxt]], [[2qxu]], [[1isp]], [[1i6w]], [[4fdm]] - BsLip – ''Bacillus subtilis''<br />
| |
| **[[3d2a]], [[3d2b]], [[3d2c]], [[1t2n]], [[1t4m]], [[3qmm]], [[3qzu]], [[4fkb]] - BsLip (mutant) <br />
| |
| **[[2ory]] – Lip – ''Photobacterium lypoliticum''<br />
| |
| **[[2z5g]], [[2dsn]] – GzLip T1 – ''Geobacillus zalihae''<br />
| |
| **[[3umj]] – GzLip (mutant)<br />
| |
| **[[3p94]] – Lip – ''Parabacteroides distasonis''<br />
| |
| **[[3ngm]] – Lip – ''Gibberella zeae''<br />
| |
| **[[3auk]] - Lip – ''Geobacillus''<br />
| |
| **[[3uue]], [[3uuf]] – Lip – ''Malassezia globosa''<br />
| |
| **[[4hs9]] – Lip – ''Proteus mirabilis''<br />
| |
| | |
| *Lipase/colipase complexes. The colipase is a co-enzyme whose binding to lipase optimizes the enzymatic activity
| |
| | |
| **[[1n8s]] – hLip+colipase II<br />
| |
| **[[1eth]], [[1lpa]] - Lip+colipase II - pig<br />
| |
| | |
| *Hormone-sensitive-lipases (LIPE) hydrolyze the first fatty acid of the triacylglycerol substrate
| |
| | |
| **[[3k6k]] – EstE7(LIPE) – metagenome library<br />
| |
| **[[3fak]], [[3dnm]] – EstE5(LIPE) – metagenome library<br />
| |
| **[[1evq]] – AaEst2(LIPE) – ''Alicyclobacillus acidocaldarius''<br />
| |
| **[[1u4n]] – AaEst2(LIPE) (mutant) <br />
| |
| | |
| *Putative lipases; Proteins with unknown function but structural similarity to lipase obtained in structural genomics projects.
| |
| | |
| **[[2rau]] - Lip – ''Sulfolobus solfataricus''<br />
| |
| **[[3bxp]], [[3d3n]] - Lip – ''Lactobacillus plantarum''<br />
| |
| **[[3e0x]] - Lip – ''Clostridium acetobutylicum''<br />
| |
| **[[1z8h]] – Lip – ''Nostoc sp.'' PCC 712<br />
| |
| **[[1vj3]] - Lip – ''Nostoc sp.'' <br />
| |
| **[[3bzw]] – Lip - ''Bacteroides thetaiotaomicron''<br />
| |
| **[[2pbl]] – Lip - ''Silicibacter''
| |
| | |
| *Lipase + inhibitors
| |
| | |
| **[[3jwe]], [[3pe6]] - mono-glyceride hLip + SAR629 – covalent inhibitor<br />
| |
| **[[3l1h]] – EstE5(LIPE)+FeCl3 – noninvasive inhibitor<br />
| |
| **[[3l1i]], [[3l1j]] - EstE5(LIPE)+CuSO4 – noninvasive inhibitor<br />
| |
| **[[3lij]] - EstE5(LIPE)+ZnSO4– noninvasive inhibitor<br />
| |
| **[[3h18]], [[3h17]] - EstE5 (LIPE)+PMSF <br />
| |
| **[[3h19]], [[3h1b]], [[3h1a]] – EstE5 (LIPE)+methyl alcohol<br />
| |
| **[[3h1a]] – EstE5 SLIPE)+ethyl alcohol<br />
| |
| **[[3h19]] – EstE5 SLIPE)+isopropyl alcohol<br />
| |
| **[[3g9t]], [[3g9u]] - EstE5 (HSLIPE)+p-nitrophenyl butyrate<br />
| |
| **[[3g9z]] - EstE5 (LIPE) +p-nitrophenyl caprylate<br />
| |
| **[[2nw6]] – BcLip+ S inhibitor <br />
| |
| **[[4lip]], [[5lip]], [[1r4z]], [[1r50]] – BcLip+ Rc-(Rp,Sp)-1,2-dioctylcarbamoyl-glycero-3-O-phosphonate<br />
| |
| **[[1r4z]] – BsLip+Rc-IPG-phosphonate <br />
| |
| **[[1r50]] - BsLip+Sc-IPG-phosphonate <br />
| |
| **[[1k8q]] - Lip+phosphonate – dog <br />
| |
| **[[1ex9]] – Lip+Rc-(Rp,Sp)-1,2-dioctylcarbamoyl-glycero-3-O-phosphonate – ''Pseudomonas aeruginosa'' <br />
| |
| **[[5tgl]] – RmLip+N-hexyl-phosphonate <br />
| |
| **[[1lpb]] – Lip (pig)+colipase+C11 alkyl phosphonate <br />
| |
| **[[3icw]] – CaLipB (mutant) +methyl hydrogen R hexylphosphonate<br />
| |
| **[[3a70]] – PsLip+diethyl phosphate<br />
| |
| **[[4glb]] – TlLip + nitrobenzaldehyde<br />
| |
| **[[4kjx]] - TlLip + nitrobenzaldehyde + lauric acid<br />
| |
| **[[4n8s]] - TlLip + nitrobenzaldehyde + ethylacetoacetate<br />
| |
| | |
| *Lipase conjugated with analogs to its reaction intermediates
| |
| | |
| **[[1lpn]], [[1lpo]], [[1lpp]] – CrLip+ sulfonates <br />
| |
| **[[3rar]] – CrLip+ phosphonate <br />
| |
| **[[1qz3]] – EaEst2(mutant) (LIPE)+hexadecanesulfonate <br />
| |
| | |
| *Lipase showing bile-salt binding site
| |
| | |
| **[[1aql]] – cBSSL+taurocholate <br />
| |
| | |
| *Monoacylglycerol lipase
| |
| | |
| **[[3rm3]], [[4lhe]] - BaMAGL – ''Bacillus'' <BR />
| |
| **[[3hju]], [[3jw8]] - hMAGL <BR />
| |
| **[[3rli]] – BaMAGL + PMSF<br />
| |
| **[[4ke7]], [[4ke8]], [[4ke9]] – BaMAGL + ligand<br />
| |
| **[[4ke6]], [[4kea]] – BaMAGL (mutant) + ligand<br />
| |
| **[[3jwe]], [[3pe6]] – hMAGL + inhibitor<br />
| |
| | |
| *Lipase with substrate bound at active site
| |
| | |
| **[[2zyh]] – AfLip (mutant)+fatty acid – ''Archaeoglobus fulgidus''<br />
| |
| **[[2zyi]], [[2zyr]], [[2zys]] - AfLip+fatty acid+ ion <br />
| |
| **[[1gt6]], [[4ghw]], [[4gi1]] – TlLip+ fatty acid - lipid ligand<br />
| |
| | |
| *Lipase conjugated to transition-state analogs showing the binding mode of the enzyme catalysis
| |
| | |
| **[[1ys1]] – BhLip+hexylphosphonic acid (R) 2-methyl-3-phenylpropyl ester <br />
| |
| **[[1ys2]] – BhLip+hexylphosphonic acid (S) 2-methyl-3-phenylpropyl ester<br />
| |
| **[[1hqd]] – Lip+1-phenoxy-2-acrtoxy butane – ''Pseudomonas cepacia'' <br />
| |
| | |
| *Lipase+lipase chaperone
| |
|
| |
|
| **[[2es4]] – Lip+lipase chaperone C-terminal - ''Burkholderia glumae''
| |
| }}
| |
| ==References== | | ==References== |
| <references /> | | <references /> |
|
| |
|
| [[Category:Topic Page]] | | [[Category:Topic Page]] |